BioSpace News Archive

Pfizer Inc. announced that the U.S. Food and Drug Administration’s Antimicrobial Drugs Advisory Committee voted 16 to 1 that available data support the safety and effectiveness of PAXLOVID™ for the treatment of mild-to-moderate COVID-19 in adult patients who are at high risk for progression to severe illness.

CymaBay Therapeutics, Inc. announced corporate updates and financial results for the year and fourth quarter ended December 31, 2022.

ProSomnus, Inc., the pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea, will report its fourth quarter and full year 2022 financial results after market close on Thursday, March 30, 2023.

Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today reported financial results for the fourth quarter and year ended December 31, 2022.

Rani Therapeutics Holdings, Inc. announced that it plans to release financial results for the fourth quarter and full year ended December 31, 2022 on Wednesday, March 22 after the close of trading.

Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the quarter ended December 31, 2022.

Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the fourth quarter and full year ended December 31, 2022.

Avail announced today that Daniel Hawkins, CEO of Avail Medsystems, will participate in a keynote panel session at Life Science Intelligence’s (LSI) Emerging MedTech Summit USA 2023.

Nanalysis Scientific Corp. announces that Company CEO Sean Krakiwsky has been invited to present on the panel “Growing Opportunities in Industrial & Medical Markets” at the Industrial Tech Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, March 21st 2023 at 1:00 p.m. ET.

Geron Corporation (Nasdaq: GERN) today reported business updates, upcoming milestones and financial results for the fourth quarter and year ended December 31, 2022.